2 weeks remaining until SMi's Pain Therapeutics Conference.

M2 PRESSWIRE-5 June 2002-SMI: 2 weeks remaining until SMi's Pain Therapeutics Conference (C)1994-2002 M2 COMMUNICATIONS LTD

RDATE:06052002

10th & 11th JUNE 2002, THE HATTON, LONDON http://www.smi-online.co.uk/painthera8.asp

The following is an overview for the Pain Therapeutics event. Critical Issues in Pain Trials for the Elderly, 12th June 2002, is a one day interactive forum in association with Quintiles. SMi is also hosting a half-day interactive forum Clinical Quantitative Sensory Testing, 12th June 2002, in association with Imperial College, Hammersmith Hospital, RDG Medical and Perimed.

Pain Therapeutics aims to explore areas such as the use of molecular targets for pain drug discovery, identification of novel analgesics, developments in narcotic drugs, results from transgenic animals and the market position for pain therapeutics.

The conference has been organised specifically to bring together leading senior executives with focused and timely information. I am sure you will agree the event will keep you abreast of all the latest developments in pain therapeutics.

DON'T MISS A ONE DAY INTERACTIVE EXECUTIVE BRIEFING

Critical Issues in Pain Trials for the Elderly 12th June 2002 The Hatton, London

DON'T MISS A HALF DAY INTERACTIVE EXECUTIVE BRIEFING

Clinical Quantitative Sensory Testing 12th June 2002 The Hatton, London

Have a scroll down, and see what you DON'T want to miss out on!

A unique opportunity to learn from leading industry experts including:

Dr Mark Field, Senior Principal Scientist, Pfizer Dr Peter McIntyre, Laboratory Head & Programme Team Head, Novartis Dr Steven England, Principal Scientist, Pfizer Dr Andy Dray, Scientific Director, AstraZeneca Dr Zahid Ali, Senior Research Pharmacologist, Merck Sharpe & Dohme Dr Robert Medve, Senior Director, Johnson & Johnson Dr David Ellis, Medical Director, Elan Dr Jenny Longmore, Pain, Migraine Research, Merck Sharpe & Dohme Dr Tony Priestley, Associate Director, Schering Plough Dr James Sullivan, Divisional Vice President, Neuroscience, Abbott

Benefits of attending:

* Keep up to date with the very latest developments in pain therapeutics

* Find out about the advances in treating different types of pain Learn about the novel drug discoveries and drug deliveries

* Take advantage of the networking opportunities

* Meet the key decision makers Establish the future prospects for pain research

CONFERENCE AGENDA

SMI'S THIRD ANNUAL PAIN THERAPEUTICS 10th & 11th JUNE 2002, THE HATTON, LONDON

Day One - 10th June 2002

8.30 Registration & Coffee

9.00 Chairman's Opening Remarks

Dr Guy Seabrook, Project Director, Merck Sharpe & Dohme

INTRODUCTION TO PAIN

9.10 Overview of opportunities in pain therapeutics

* Market opportunity

* Issues with existing therapies

* Unmet medical need

* Key factors for success of new compounds

* Major obstacles to success

Dr Steven England, Principal Scientist, Pfizer

PAIN MANAGEMENT

9.40 Therapies, drug delivery and analgesics

* Epidemiology and market segmentation

* Current treatments for chronic pain

* Emerging therapies

* The role of drug delivery technology in pain management

* The search for new analgesics…